Skip to main content
logo
Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
7.80
-0.33 (-4.06%)
Jul 9, 2026, 3:06 PM EDT - Market open

Puma Biotechnology Revenue

Puma Biotechnology had revenue of $44.81M in the quarter ending March 31, 2026, a decrease of -2.59%. This brings the company's revenue in the last twelve months to $227.18M, down -2.38% year-over-year. In the year 2025, Puma Biotechnology had annual revenue of $228.37M, down -0.91%.

Revenue (ttm)
$227.18M
Revenue Growth
-2.38%
P/S Ratio
1.75
Revenue / Employee
$1,269,151
Employees
179
Market Cap
397.02M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025228.37M-2.10M-0.91%
Dec 31, 2024230.47M-5.17M-2.19%
Dec 31, 2023235.64M7.61M3.34%
Dec 31, 2022228.03M-25.12M-9.92%
Dec 31, 2021253.16M28.05M12.46%
Dec 31, 2020225.11M-47.15M-17.32%
Dec 31, 2019272.26M21.27M8.47%
Dec 31, 2018250.99M223.31M806.60%
Dec 31, 201727.69M--
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Century Therapeutics109.16M
Autolus Therapeutics92.62M
Enanta Pharmaceuticals69.21M
vTv Therapeutics36.84M
Evommune10.00M
Adlai Nortye5.00M
Upstream Bio3.32M
Compass Therapeutics850.00K
Revenue Rankings

PBYI News

More News